Your cart is empty
Browse transcripts and add items to get started.
Lockheed Martin posted Q1 2026 sales of $18.0 billion, roughly flat year-over-year, while EPS fell to $6.44 from $7.28 as segment operating profit declined 13% driven by unfavorable profit adjustments across Aeronautics, RMS, and Space. Management reaffirmed full-year guidance calling for approximately 5% sales growth and 25% operating profit growth, anchored by a landmark munitions production framework with the Department of War.
Performance Highlights
Lockheed Martin reported Q1 2026 sales of $18.0 billion, essentially flat versus $18.0 billion in Q1 2025, coming in line with expectations, while diluted EPS of $6.44 missed the prior-year comparable of $7.28 as consolidated operating profit fell 13% to $2.1 billion. The headline earnings shortfall reflected a $262 million, or 13%, decline in business segment operating profit to $1.8 billion, with segment operating margin compressing from 11.6% to 10.1%.
The single most important driver of the profit decline was a wave of unfavorable profit booking rate adjustments totalling $125 million on the F-16 program, $55 million on C-130, and the absence of an $80 million favorable classified-program adjustment from Q1 2025, partially offset by $130 million of higher favorable adjustments on F-35 sustainment. MFC was the standout bright spot, growing sales 8% to $3.6 billion and operating profit 8% to $500 million on PAC-3, JASSM, LRASM, and PrSM production ramp-ups, while RMS and Space both saw operating profit fall roughly 19–26% on non-recurring items.
Management Outlook and Forward Catalysts
Management reaffirmed its 2026 full-year guidance of $77.5–$80.0 billion in sales, $8.4–$8.7 billion in segment operating profit, diluted EPS of $29.35–$30.25, and free cash flow of $6.5–$6.8 billion, signalling confidence that Q1 headwinds are transitory and that accelerating production ramp-ups will drive a strong back-half recovery. The pivotal strategic development was the signing of multiyear framework agreements with the Department of War to scale PAC-3 output threefold, and THAAD and PrSM fourfold, underpinned by $8–9 billion of investment through 2030 and a projected mid-teens five-year sales CAGR for MFC.
The central investor debate heading into Q2 centres on whether the F-16 and C-130 production execution issues are contained one-quarter events or signal deeper fixed-price contract risk, and whether free cash flow, which swung to negative $291 million from positive $955 million in Q1 2025 on working capital timing, will recover sufficiently to underpin the $6.5–$6.8 billion full-year target. Bulls will focus on the structural demand tailwind from NATO rearming and the munitions framework agreements; bears will watch F-35 delivery cadence, which fell to 32 aircraft from 47 a year ago, and the potential CAMT tax policy impact on cash flows.
Adjusted EPS vs. consensus breakdown — primary performance driver, segment revenue contribution, and gross margin trajectory relative to prior guidance...
Segment-by-segment revenue analysis, margin profile, and management commentary on demand trajectory vs. consensus range expectations...
Forward guidance implications for the sector, supply chain read-throughs, and investment implications for the broader competitive landscape...